GSK Launches Phase 3 Cryopreserved Gene Therapy Clinical Trial - MLD Foundation Blog
New Clinical Trial for MLD GSK has just launched a Phase 3 clinical trial to study the efficacy of a cryopreserved formulation of their gene therapy, i.e. freezing the modified cells before transfusion. Recruiting of pre-symptomatic late infantile and early … Continue reading →